{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bronchodilator+Agents&page=2", "query": { "condition": "Bronchodilator Agents", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bronchodilator+Agents&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-22T12:27:13.969Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01349673", "title": "The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Proctitis", "Proctosigmoiditis" ], "interventions": [ { "name": "Budesonide Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 114, "start_date": "2011-05-31", "completion_date": "2014-12-31", "has_results": true, "last_update_posted_date": "2019-08-14", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01349673" }, { "nct_id": "NCT01902290", "title": "Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Brodalumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 421, "start_date": "2013-05-22", "completion_date": "2015-05-15", "has_results": true, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 64 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01902290" }, { "nct_id": "NCT01323660", "title": "An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "GSK573719/GW642444 125/25", "type": "DRUG" }, { "name": "GSK573719/GW642444 62.5/25", "type": "DRUG" }, { "name": "GSK573719 125", "type": "DRUG" }, { "name": "GSK573719 62.5", "type": "DRUG" }, { "name": "GW642444 25", "type": "DRUG" }, { "name": "placebo", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 307, "start_date": "2011-03-16", "completion_date": "2012-07-16", "has_results": true, "last_update_posted_date": "2018-02-15", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 18, "location_summary": "Jasper, Alabama • Torrance, California • Fort Collins, Colorado + 15 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Torrance", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01323660" }, { "nct_id": "NCT01641081", "title": "Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Formoterol Fumarate in the Pressair DPI, Low Dose", "type": "DRUG" }, { "name": "Formoterol Fumarate in the Pressair DPI, High Dose", "type": "DRUG" }, { "name": "Foradil Aerolizer, Low Dose", "type": "DRUG" }, { "name": "Foradil Aerolizer, High Dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 174, "start_date": "2012-06", "completion_date": "2013-02", "has_results": true, "last_update_posted_date": "2017-02-28", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 29, "location_summary": "Phoenix, Arizona • Encinitas, California • Los Angeles, California + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01641081" }, { "nct_id": "NCT01737892", "title": "Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation", "type": "DRUG" }, { "name": "Arm C-Epinephrine Inhalation Aerosol CFC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 21, "start_date": "2012-11", "completion_date": "2012-11", "has_results": false, "last_update_posted_date": "2016-03-17", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01737892" }, { "nct_id": "NCT05083312", "title": "Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "APT-1011", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ellodi Pharmaceuticals, LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 6, "start_date": "2021-09-30", "completion_date": "2022-09-05", "has_results": false, "last_update_posted_date": "2023-09-21", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 2, "location_summary": "Indianapolis, Indiana • Boston, Massachusetts", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05083312" }, { "nct_id": "NCT01836471", "title": "A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QAW039", "type": "DRUG" }, { "name": "Placebo QAW039", "type": "DRUG" }, { "name": "Fluticasone 250 mcg", "type": "DRUG" }, { "name": "Fluticasone 100 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 345, "start_date": "2013-05", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 30, "location_summary": "Encinitas, California • Huntington Beach, California • Los Angeles, California + 24 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01836471" }, { "nct_id": "NCT00791518", "title": "Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "No intervention", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1084, "start_date": "2008-12", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2014-07-30", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "National City", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00791518" }, { "nct_id": "NCT05634746", "title": "24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "APT-1011", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" }, { "name": "Esophagogastroduodenoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Ellodi Pharmaceuticals, LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 218, "start_date": "2022-12-29", "completion_date": "2024-08-12", "has_results": false, "last_update_posted_date": "2025-08-13", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 59, "location_summary": "Dothan, Alabama • Mobile, Alabama • Scottsdale, Arizona + 54 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05634746" }, { "nct_id": "NCT03137784", "title": "Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "NVA237 (glycopyrronium bromide)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 148, "start_date": "2017-05-04", "completion_date": "2017-12-29", "has_results": true, "last_update_posted_date": "2019-01-16", "last_synced_at": "2026-07-22T12:27:13.969Z", "location_count": 6, "location_summary": "North Dartmouth, Massachusetts • St Louis, Missouri • Skillman, New Jersey + 3 more", "locations": [ { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03137784" } ] }